Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 8Classical hematology 5Gastrointestinal 3Thoracic 2Plasma cell 1Myeloid 1Lymphoid 1Breast 1

Conditions

Lymphoma 550Precursor Cell Lymphoblastic Leukemia-Lymphoma 514Lymphoma, Non-Hodgkin 437Lymphoma, Follicular 405Leukemia, Lymphocytic, Chronic, B-Cell 393Lymphoma, Large B-Cell, Diffuse 392Lymphoma, B-Cell 247Lymphoma, Mantle-Cell 223Hodgkin Disease 210Recurrence 202Leukemia, Myeloid, Acute 201Leukemia 195Multiple Myeloma 185Burkitt Lymphoma 185Lymphoma, B-Cell, Marginal Zone 170Neoplasms 152Myelodysplastic Syndromes 135Hematologic Neoplasms 115Waldenstrom Macroglobulinemia 103Lymphoma, T-Cell, Peripheral 87Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 83Lymphoma, T-Cell 82Lymphoma, T-Cell, Cutaneous 67Leukemia, Myelogenous, Chronic, BCR-ABL Positive 64Mycosis Fungoides 57Leukemia, Biphenotypic, Acute 55Breast Neoplasms 55Leukemia, B-Cell 53Myeloproliferative Disorders 50Lymphoproliferative Disorders 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × Lymphoid × 1 year × Clear all
NCT04618081 2025-07-08

Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

Celgene

Completed
151 enrolled
Lymphoid

Bone Marrow Failure Disorders, Lymphoma, Lymphoma, Non-Hodgkin, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡